Mylan (MYL) announced that it would launch the first generic to its allergy auto-injector at a discount of more than 50% to the branded product's list price. The device will be identical to the branded product, including functionality and drug formulation. Mylan expects to release the $300 two-pack carton in several weeks, pending completion of labeling revisions.